Login

Unveiling Norseman: A Glimpse into Fiercely Reliable Fabric Buildings | Ron Bryant - CEO at Norseman 00:10:00

Share On Facebook Share On Twitter

Ron Bryant is the CEO at Norseman

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Valens Semiconductor CEO Gideon Ben-Zvi discusses moving data through cables and related innovations.
00:10:00
Amazon's Potential in Healthcare: Expanding Pharmacy, Tech, and Home Services"
00:10:00
Invests in female-led companies working on improving the way we live|Leslie Feinzaig,Founder and Managing Director,Graham & Walker
00:10:00
Eagle Plains' Spin-Off and New Exploration Ventures: Tim Turmani on Royalties and the Vulcan Project
00:10:00
driven to push humanity forward|Aneel Ranadive,Managing Partner,Soma Capital
00:10:00
Flucas Ventures is a sector stage and geography agnostic investor|Ashley Flucas,Founder,Flucas Ventures
00:10:00
Exploring Apollo's Strategic Shifts and Investment Outlook in Credit Markets | James Zelter, Co-president, Apollo Global Management.
00:10:00
Perspectives on Pakistan, Education Programs, and Banking Sector Insights|Rehmat Ali Hasnie,CEO,National Bank of Pakistan
00:10:00
Year-End Financial Checklist and Heartfelt Thanks
00:10:00
Fund is a venture captal fund managed by Belltower Fund Group|Immad Akhund,Investor,Immad Akhund Fund
00:10:00
Butterfield Investments: Generational Expertise and Company Retirement Plans
00:10:00
Chrysos Corp 1H FY24 Webcast Highlights | Brett Coventry, Chief Financial Officer of Chrysos Corporation Limited

© 2026 Nehu